Metastatic Neuroendocrine Tumor (NET) to the pineal gland is a unique manifestation previously unreported in the literature. We describe an unusual case of metastatic bronchial NET to the pineal gland in a 71-year-old male patient. His primary NET had been resected six years previously and there was no indication of the presence of disseminated metastatic disease at that time. Due to increased uptake by the pituitary gland on the post-operative 111 Indium-pentetreotide scintigraphy (Octreoscan), an intra-sellar mass was diagnosed and excised using a transsphenoidal approach; histology revealed an unrelated non-functional pituitary macroadenoma. Four years later, a new mass appeared on MRI, involving the pineal gland, and was diagnosed on biopsy as a metastatic lesion from the original bronchial NET. Since this lesion was not accessible to surgery, it was treated successfully with radiosurgery. The case suggests that NETs should be considered in the differential diagnosis of pineal gland metastases and that radiosurgery may be an effective alternative in the treatment of these patients.
intRoduction
The pineal gland is located in the posterodorsal aspect of the diencephalon. Its secretory product, melatonin, has a variety of potentially important effects in humans, including anticancer, antihypertensive and antioxidant action. Moreover melatonin can act as a protector against ischemia/reperfusion injury. [1] [2] [3] [4] Primary tumors of the pineal region can be of variable origin, the most commonly reported being germ cell tumors which arise from developmental abnormalities, and pineal cell tumors which develop from pinealocytes themselves. 5 Metastatic tumors of the pineal gland are rarely reported in the literature, reaching a 4% incidence in patients with disseminated neoplasia originating from breast, lung or colon. 6 Most metastatic pineal lesions are asymptomatic, being incidentally discovered during conventional imaging procedures for disease staging.
Bronchial Neuroendocrine Tumors (NETs) range from the well-differentiated NET to the more aggressive, poorly differentiated NET. The tumor classification is extremely important, as the latter category is usually associated with a worse prognosis and a shorter survival. 7 To our knowledge, the present case is the first in which the pineal gland was apparently a unique metastatic site of a bronchial NET.
case RepoRt
A 71-year-old man developed gradual pressure headaches. Six years previously he had complained of prolonged cough and hemoptysis, and a 2 cm lesion on the right lung was diagnosed. The patient underwent a trans-bronchial biopsy which raised the suspicion of a small cell lung carcinoma, and therefore a right pneumonectomy was performed. The pathological report revealed a NET invading the entire bronchial wall, the external aspect of the main pulmonary vessels and three hilar lymph nodes, with areas of cellular pleomorphism; the mitotic count was increased (5 mitoses/10 HPF) as was the Ki-67 proliferation index (about 20%) without necrosis. Positive staining for neuroendocrine markers (chromogranin A, synaptophysin and neuron-specific enolase) was demonstrated on immunohistochemistry.
Following the operation, the patient was free of any NET-related symptoms, such as flushing, diarrhea, wheezing or palpitations; physical examination and laboratory tests were all normal, including complete blood count, biochemistry and 24 hours urine collection for 5-Hydroxyindoleacetic Acid (5-HIAA). An 111 Indium-pentetreotide scintigraphy (Octreoscan) was then performed: this procedure usually reflects the functional accumulation of the Somatostatin (SST) analogue octreotide in tissues expressing SST receptors, such as NETs, and possesses a high diagnostic accuracy. 8 The scintigraphy revealed an intense area of uptake inside the pituitary gland. A subsequent MRI of the brain discovered a 2.5 cm pituitary macroadenoma. Pituitary hormone tests were all normal and a transsphenoidal resection of the pituitary tumor was performed, revealing an unrelated, nonfunctional pituitary adenoma.
The patient was followed with yearly computerized tomography of the chest and brain, without any pathological finding until four years later, when a CT and a subsequent MRI of the brain revealed a 1 cm round lesion in the area of the pineal gland ( Figure  1 ). The lesion did not show an uptake on repeated Octreoscan and, due to its small size, a biopsy could not be initially performed at that time. Repeated brain MRI, six months ( Figure 2 ) and 12 months later (Figure 3) , demonstrated progressive increase in the size of the pineal mass, up to 2.5 cm. Based on tumor location, the patient was referred for an endoscopic image-guided biopsy of the pineal lesion: this is a minimally invasive and safe procedure, performed via an operating sheath and having a good diagnostic yield. In our patient this approach revealed a metastatic NET ( Figure 4A ), which demonstrated a lower Ki-67 proliferation index (8%) than the primary tumor ( Figure 4B ). 9 While pineal cells are known to naturally stain for S-antigen and synaptophysin, this latter marker together with other NET markers (such as chromogranin A and neuron-specific enolase) are prognostically important to be assessed in NETs; indeed, positive staining for chromogranin A and synaptophysin was demonstrated on immunohistochemistry in our patient's pineal metastasis ( Figure 4C ). 11 Repeated laboratory tests for neuroendocrine markers, including 24 hours urinary collection for 5-HIAA and serum Chromogranin A (CgA), were within normal limits (5-HIAA = 3.9 mg/24h, normal 2-10; CgA = 47 ng/ml, normal 19-98).
The patient was successfully treated with radiosurgery, as demonstrated by repeated MRI, performed during the follow-up period that showed tumor regression. Due to the co-existence of the bronchial The prognosis of patients with tumoral involvement of the pineal gland depends on the etiology and the treatment modalities. The overall mean survival time in patients with primary pineal tumors is approximately 66 months, while the reported 3-year survival rate is about 84%. 21 However, in patients with disseminated malignancies, the survival depends on the aggressiveness of the primary tumor (based on cell morphology, mitotic rate, Ki-67 proliferation index, etc), as well as on the metastatic burden. In our patient the Ki-67 was lower in the metastatic tissue than in the primary tumour, a difference in the Ki-67 index having previously reported; this finding indicates heterogeneity in the proliferation rates between the primary and the metastatic cells, developing from a common tumoral clone. 10 In conclusion, the case herein presented suggests that metastatic neuroendocrine tumors should be considered in the differential diagnosis of pineal gland tumors, particularly in elder people. It also indicates that radiosurgery may be effective in the treatment of these patients. When a metastatic tumor destroys the majority of functional pineal tissue, then consequences due to the reduction in melatonin may have to be considered. [1] [2] [3] [4] This would also be a consideration when the gland is destroyed by the treatment, as in our patient. tastasis to the pineal gland was described in 1858 by Forster, while other malignant tumors metastatic to the pineal have included breast and bronchogenic carcinomas, melanoma, renal cell, pancreatic, ovarian, gastric and frontal sinus carcinomas, in decreasing frequency. 12, 13 Widespread metastatic disease is the usual finding in most described cases and the time from the diagnosis of the primary tumor to the onset of Central Nervous System (CNS) symptoms (such as vertigo, confusion, headaches or vertical eye gaze paralysis) is variable. [14] [15] [16] It is widely accepted that pineal involvement in these patients does not result in direct symptoms, which are usually produced through distortion of surrounding structures by pineal masses. 17 Rarely, the symptoms of metastatic pineal gland involvement may precede those of the primary tumor or other metastatic sites. 18 Moreover, pineal involvement by a metastatic tumor may disturb melatonin secretion, with resultant implications for multiple processes such as immunomodulation, antioxidant capacity, stress-response, cancer protection, etc. 19 Many cases of pineal metastases have been diagnosed at autopsy. The proximity of these tumors to vital brain structures limits one's ability to perform biopsies of these lesions and to reach an accurate diagnosis. 12 Therefore, important factors in differentiating metastatic disease from a primary pineal gland tumor are a history of malignancy and the age of the patient, children and young adults being more frequently affected by primary pineal tumors. 20 To our knowledge, the present case is the first in which the pineal gland was apparently a unique metastatic site of a neuroendocrine tumor. The patient was symptomatic, complaining of headaches. The diagnosis was based on the positive history of a primary bronchial NET, the patient's age and, mainly, on the positive findings revealed by the endoscopic biopsy of the pineal mass.
The usual approach in the management of these patients includes surgery by the Occipital Trans-Tentorial approach (OTT) followed, when necessary, by regional radiotherapy; the surgical complications are mostly transient. However, in our patient, the surgical excision of the pineal metastasis was limited by tumor size and tumor localization; therefore, the patient was referred to guided radiosurgery. 21 
